SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-06-001409
Filing Date
2006-03-23
Accepted
2006-03-23 11:33:58
Documents
11
Period of Report
2006-04-26
Effectiveness Date
2006-03-23

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. w18794def14a.htm DEF 14A 248652
2 GRAPHIC w18794w1879409.gif GRAPHIC 6074
3 GRAPHIC w18794w1879400.gif GRAPHIC 1729
4 GRAPHIC w18794w1879401.gif GRAPHIC 873
5 GRAPHIC w18794w1879408.gif GRAPHIC 903
6 GRAPHIC w18794w1879402.gif GRAPHIC 377
7 GRAPHIC w18794w1879403.gif GRAPHIC 870
8 GRAPHIC w18794w1879404.gif GRAPHIC 2736
9 GRAPHIC w18794w1879405.gif GRAPHIC 913
10 GRAPHIC w18794w1879406.gif GRAPHIC 2030
11 GRAPHIC w18794w1879407.gif GRAPHIC 1388
  Complete submission text file 0000950133-06-001409.txt   276232
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 06705331
SIC: 2836 Biological Products, (No Diagnostic Substances)